Conflict of interest, protection of public ownership, in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry [microform] : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session.
United States.Congress.House.Committee on Small Business.Subcommittee on Regulation, Business Opportunities, and Technology.
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,
1993-
"Washington, DC, March 11, 1993"--Pt. 1.
Includes bibliographical references.
"Serial no. 103-5"--Pt. 1.
Microfiche.
Drugs
Drugs
Research and development contracts, Government
Pharmaceutical industry
Conflict of interests